JP2008513498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008513498A5 JP2008513498A5 JP2007532629A JP2007532629A JP2008513498A5 JP 2008513498 A5 JP2008513498 A5 JP 2008513498A5 JP 2007532629 A JP2007532629 A JP 2007532629A JP 2007532629 A JP2007532629 A JP 2007532629A JP 2008513498 A5 JP2008513498 A5 JP 2008513498A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- group
- independently selected
- rings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 74
- 239000001257 hydrogen Substances 0.000 claims 74
- 125000000217 alkyl group Chemical group 0.000 claims 53
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 46
- 125000003118 aryl group Chemical group 0.000 claims 40
- 125000000753 cycloalkyl group Chemical group 0.000 claims 40
- 125000001072 heteroaryl group Chemical group 0.000 claims 40
- 125000000623 heterocyclic group Chemical group 0.000 claims 40
- 125000003710 aryl alkyl group Chemical group 0.000 claims 33
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 33
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 28
- 150000002431 hydrogen Chemical class 0.000 claims 28
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 22
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 22
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 22
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 22
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 22
- 125000003367 polycyclic group Chemical group 0.000 claims 18
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 16
- 125000001309 chloro group Chemical group Cl* 0.000 claims 16
- 125000001153 fluoro group Chemical group F* 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 125000004043 oxo group Chemical group O=* 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 8
- 239000000651 prodrug Substances 0.000 claims 8
- 229940002612 prodrug Drugs 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 101000631826 Homo sapiens Stearoyl-CoA desaturase Proteins 0.000 claims 6
- 102000055981 human SCD1 Human genes 0.000 claims 6
- 108010087894 Fatty acid desaturases Proteins 0.000 claims 4
- 102000016553 Stearoyl-CoA Desaturase Human genes 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- 208000004930 Fatty Liver Diseases 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000010706 fatty liver disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 2
- WFNHQQPAILHHHY-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-(3-methylbutyl)imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCC(C)C)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F WFNHQQPAILHHHY-UHFFFAOYSA-N 0.000 claims 1
- IJUINEMMNVBKSC-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-hexylimidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F IJUINEMMNVBKSC-UHFFFAOYSA-N 0.000 claims 1
- CQKHBKHSSXUYNW-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-pentylimidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F CQKHBKHSSXUYNW-UHFFFAOYSA-N 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- CHANIKOYXKLUJA-UHFFFAOYSA-N [4-(2-butylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F CHANIKOYXKLUJA-UHFFFAOYSA-N 0.000 claims 1
- PZGGHBAFDRRBJC-UHFFFAOYSA-N [4-(2-ethylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F PZGGHBAFDRRBJC-UHFFFAOYSA-N 0.000 claims 1
- UWEIAULOMZAVFL-UHFFFAOYSA-N [4-(2-pentyl-3h-benzimidazol-5-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C=1C=C2NC(CCCCC)=NC2=CC=1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F UWEIAULOMZAVFL-UHFFFAOYSA-N 0.000 claims 1
- AECMFRRWQZBFCY-UHFFFAOYSA-N [4-(2-pentylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F AECMFRRWQZBFCY-UHFFFAOYSA-N 0.000 claims 1
- UKFUGRVXZDKAHC-UHFFFAOYSA-N [4-(2-propyl-3h-benzimidazol-5-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C=1C=C2NC(CCC)=NC2=CC=1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F UKFUGRVXZDKAHC-UHFFFAOYSA-N 0.000 claims 1
- UXIXHNZAEPVELV-UHFFFAOYSA-N butanamide 6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid Chemical compound C(CCC)(=O)N.FC(C1=C(C(=O)N2CCN(CC2)C=2C=CC=3N(N2)C=C(N3)C(=O)O)C=CC=C1)(F)F UXIXHNZAEPVELV-UHFFFAOYSA-N 0.000 claims 1
- QRRCXKJNOUZZDS-UHFFFAOYSA-N butanamide 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid Chemical compound C(CCC)(=O)N.FC=1C=CC(=C(C(=O)N2CCN(CC2)C=2C=CC=3N(N2)C=C(N3)C(=O)O)C1)C(F)(F)F QRRCXKJNOUZZDS-UHFFFAOYSA-N 0.000 claims 1
- LAFZMBWMUSXBPY-UHFFFAOYSA-N n-(3-cyclopropylpropyl)-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound FC1=CC=C(C(F)(F)F)C(C(=O)N2CCN(CC2)C2=NN3C=C(N=C3C=C2)C(=O)NCCCC2CC2)=C1 LAFZMBWMUSXBPY-UHFFFAOYSA-N 0.000 claims 1
- QNWVQJMOJXPWFC-UHFFFAOYSA-N n-(4-fluorophenyl)-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=CC=3)C(F)(F)F)C2=N1 QNWVQJMOJXPWFC-UHFFFAOYSA-N 0.000 claims 1
- PMFPUIKGZQZPBB-UHFFFAOYSA-N n-(5-chloropyridin-2-yl)-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N1CCN(C2=NN3C=C(N=C3C=C2)C(=O)NC=2N=CC(Cl)=CC=2)CC1 PMFPUIKGZQZPBB-UHFFFAOYSA-N 0.000 claims 1
- RWGDYMLWUNTSIJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=CC=3)C(F)(F)F)C2=N1 RWGDYMLWUNTSIJ-UHFFFAOYSA-N 0.000 claims 1
- SHBVWULGQNELRK-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=C(F)C=3)C(F)(F)F)C2=N1 SHBVWULGQNELRK-UHFFFAOYSA-N 0.000 claims 1
- IPPLKHPXLPDXSZ-UHFFFAOYSA-N n-[2-(4-fluorophenyl)ethyl]-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CCNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=C(F)C=3)C(F)(F)F)C2=N1 IPPLKHPXLPDXSZ-UHFFFAOYSA-N 0.000 claims 1
- HLNLHSIUBXRMAW-UHFFFAOYSA-N n-pentyl-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F HLNLHSIUBXRMAW-UHFFFAOYSA-N 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 0 CCNC(C(C)C(C)(C(*)C(*)(*)CCC(C)(*)C(C)C)*=C)C1CCCCC1 Chemical compound CCNC(C(C)C(C)(C(*)C(*)(*)CCC(C)(*)C(C)C)*=C)C1CCCCC1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61164604P | 2004-09-20 | 2004-09-20 | |
| US60/611,646 | 2004-09-20 | ||
| PCT/US2005/033738 WO2006034312A1 (en) | 2004-09-20 | 2005-09-20 | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133967A Division JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008513498A JP2008513498A (ja) | 2008-05-01 |
| JP2008513498A5 true JP2008513498A5 (enExample) | 2008-10-30 |
| JP5080256B2 JP5080256B2 (ja) | 2012-11-21 |
Family
ID=35623357
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532629A Expired - Fee Related JP5080256B2 (ja) | 2004-09-20 | 2005-09-20 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
| JP2012133967A Withdrawn JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133967A Withdrawn JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7547698B2 (enExample) |
| EP (1) | EP1804792A1 (enExample) |
| JP (2) | JP5080256B2 (enExample) |
| CN (1) | CN101083986A (enExample) |
| AR (1) | AR051294A1 (enExample) |
| AU (1) | AU2005286790A1 (enExample) |
| BR (1) | BRPI0515477A (enExample) |
| CA (1) | CA2580781A1 (enExample) |
| MX (1) | MX2007003329A (enExample) |
| TW (1) | TW200626148A (enExample) |
| WO (1) | WO2006034312A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US7767677B2 (en) * | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| EP1799667B1 (en) | 2004-09-20 | 2013-03-20 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
| JP4958787B2 (ja) * | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリジン誘導体 |
| CA2580856A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| EP2316458A1 (en) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| EP1804799B1 (en) * | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| EP2289510A1 (en) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| RU2384576C2 (ru) | 2004-10-29 | 2010-03-20 | Калипсис, Инк | Сульфонил-замещенные бициклические соединения в качестве модуляторов ppar |
| EP2029138A1 (en) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| EP1902051A1 (en) * | 2005-06-09 | 2008-03-26 | Merck Frosst Canada Ltd. | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| KR101464767B1 (ko) | 2005-10-25 | 2014-11-24 | 칼립시스, 인코포레이티드 | Ｐｐａｒ의 조절자의 염 및 대사질환을 치료하는 방법 |
| WO2007071023A1 (en) | 2005-12-20 | 2007-06-28 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| DE602007010287D1 (de) | 2006-06-05 | 2010-12-16 | Novartis Ag | Organische verbindungen |
| BRPI0719122A2 (pt) | 2006-08-24 | 2013-12-10 | Novartis Ag | Compostos orgânicos |
| US20090325956A1 (en) * | 2006-10-13 | 2009-12-31 | Takahiko Taniguchi | Aromatic amine derivative and use thereof |
| TW200826936A (en) | 2006-12-01 | 2008-07-01 | Merck Frosst Canada Ltd | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
| WO2008096746A1 (ja) | 2007-02-06 | 2008-08-14 | Takeda Pharmaceutical Company Limited | スピロ化合物およびその用途 |
| AU2008253512A1 (en) * | 2007-05-23 | 2008-11-27 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| US7842696B2 (en) | 2007-06-21 | 2010-11-30 | Forest Laboratories Holdings Limited | Piperazine derivatives as inhibitors of stearoyl-CoA desaturase |
| EA201000051A1 (ru) * | 2007-07-13 | 2010-08-30 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Противовирусные соединения, композиции и способы использования |
| WO2009012573A1 (en) * | 2007-07-20 | 2009-01-29 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| CA2719362A1 (en) * | 2008-04-04 | 2009-10-08 | Gilead Sciences, Inc. | Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| JP2011516498A (ja) | 2008-04-04 | 2011-05-26 | ギリアード サイエンシーズ， インコーポレイテッド | ステアロイル−ＣｏＡデサチュラーゼの阻害剤として使用するためのトリアゾロピリジノン誘導体 |
| WO2010094120A1 (en) | 2009-02-17 | 2010-08-26 | Merck Frosst Canada Ltd. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| US8383643B2 (en) | 2009-07-28 | 2013-02-26 | Merck Canada Inc. | Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| EP2475367A1 (en) | 2009-09-10 | 2012-07-18 | Centre National De La Recherche Scientifique | NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| JP5541454B2 (ja) * | 2009-09-16 | 2014-07-09 | Ｊｓｒ株式会社 | 液晶配向剤および液晶表示素子 |
| CN102971311B (zh) | 2010-05-06 | 2015-07-08 | 百时美施贵宝公司 | 作为gpr119调节剂的二环杂芳基化合物 |
| WO2011153359A1 (en) | 2010-06-04 | 2011-12-08 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| US8993626B2 (en) | 2010-06-25 | 2015-03-31 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treatment using sterculic acid |
| US9358250B2 (en) | 2011-10-15 | 2016-06-07 | Genentech, Inc. | Methods of using SCD1 antagonists |
| WO2013134546A1 (en) | 2012-03-07 | 2013-09-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| MX2014014174A (es) | 2012-05-22 | 2015-07-06 | Hoffmann La Roche | Inhibidores selectivos de celulas no diferenciadas. |
| KR20150090100A (ko) * | 2012-12-03 | 2015-08-05 | 에프. 호프만-라 로슈 아게 | 스테아로일-CoA 불포화화효소 1(에스씨디 1)의 억제제로서의 치환된 이속사졸 아마이드 화합물 |
| MD20150071A2 (ro) | 2013-02-19 | 2016-02-29 | Pfizer Inc. | Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni |
| WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| EA031201B1 (ru) | 2014-08-06 | 2018-11-30 | Пфайзер Инк. | Соединения имидазопиридазина |
| WO2016022955A1 (en) | 2014-08-07 | 2016-02-11 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| EP3529245A4 (en) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
| MA47212A (fr) | 2017-01-06 | 2019-11-13 | Yumanity Therapeutics Inc | Méthodes de traitement de troubles neurologiques |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| CA3182500A1 (en) * | 2020-05-22 | 2021-11-25 | Vanderbilt University | Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5 |
Family Cites Families (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
| US3830924A (en) * | 1966-12-23 | 1974-08-20 | American Cyanamid Co | Substituted nitroimidazolyl-thiadiazoles as growth promoting agents |
| GB1290145A (enExample) * | 1969-01-21 | 1972-09-20 | ||
| AT340933B (de) * | 1973-08-20 | 1978-01-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze |
| DE2516040C2 (de) * | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4247551A (en) * | 1979-09-17 | 1981-01-27 | Gruppo Lepetit S.P.A. | N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents |
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| CH653021A5 (fr) * | 1981-04-24 | 1985-12-13 | Delalande Sa | Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant. |
| DE3139970A1 (de) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| US4439606A (en) * | 1982-05-06 | 1984-03-27 | American Cyanamid Company | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| DE3827599A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Verwendung von optisch aktiven tetrahydrofuran-2-carbonsaeureestern als dotierstoffe in fluessigkristallmischungen, diese enthaltende fluessigkristallmischungen und neue optisch aktive tetrahydrofuran-2-carbonsaeureester |
| EP0471201A1 (de) * | 1990-07-21 | 1992-02-19 | Hoechst Aktiengesellschaft | Neue Oxazolidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| EP0520292A1 (de) * | 1991-06-19 | 1992-12-30 | Hoechst Aktiengesellschaft | Chirale Azetidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| EP0524146A1 (de) * | 1991-07-19 | 1993-01-20 | Ciba-Geigy Ag | Aminosubstituierte Piperazinderivate |
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH05345780A (ja) * | 1991-12-24 | 1993-12-27 | Kumiai Chem Ind Co Ltd | ピリミジンまたはトリアジン誘導体及び除草剤 |
| DE4236106A1 (de) * | 1992-10-26 | 1994-04-28 | Hoechst Ag | Azaaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssigkristallinen Mischungen |
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| US5380726A (en) * | 1993-01-15 | 1995-01-10 | Ciba-Geigy Corporation | Substituted dialkylthio ethers |
| US5547605A (en) * | 1993-12-15 | 1996-08-20 | Hoechst Aktiengesellschaft | 2-Aryloxytetrafluoropropionic esters, process for their preparation, and their use in liquid-crystalline mixtures |
| US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
| US5668148A (en) * | 1995-04-20 | 1997-09-16 | Merck & Co., Inc. | Alpha1a adrenergic receptor antagonists |
| DE19517038A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1,8-Difluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517025A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | Trifluortetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517051A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-6,7-dihydro-5H-isochinolin-8-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517056A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-5,6,7,8-tetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517060A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| ZA969622B (en) * | 1995-12-13 | 1998-05-15 | Upjohn Co | Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring. |
| CA2266519C (en) * | 1996-10-02 | 2007-01-23 | Novartis Ag | Pyrimidine derivatives and processes for the preparation thereof |
| DE59707681D1 (de) * | 1996-10-28 | 2002-08-14 | Rolic Ag Zug | Vernetzbare, photoaktive Silanderivate |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| ES2325140T3 (es) * | 1998-04-20 | 2009-08-26 | ABBOTT GMBH & CO. KG | Amidas sustituidas con heterociclos como inhibidores de la calpaina. |
| DE69919361T2 (de) * | 1998-08-25 | 2005-09-08 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung |
| ATE256128T1 (de) * | 1998-10-21 | 2003-12-15 | Takeda Chemical Industries Ltd | Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung |
| FR2792314B1 (fr) * | 1999-04-15 | 2001-06-01 | Adir | Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9912413D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| US6127382A (en) * | 1999-08-16 | 2000-10-03 | Allergan Sales, Inc. | Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| US6677452B1 (en) * | 1999-09-30 | 2004-01-13 | Lion Bioscience Ag | Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof |
| EP1315831B8 (en) * | 2000-02-24 | 2010-09-01 | Xenon Pharmaceuticals Inc. | Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| ATE374765T1 (de) * | 2000-07-27 | 2007-10-15 | Lilly Co Eli | Substituierte heterocyclische amide |
| HRP20030081A2 (en) * | 2000-08-08 | 2005-02-28 | Sanofi-Aventis | Benzimidazole derivatives, preparation and therapeutic use thereof |
| US6738895B1 (en) * | 2000-08-31 | 2004-05-18 | Micron Technology, Inc. | Method and system for substantially registerless processing |
| EP1322767B1 (en) | 2000-09-26 | 2008-07-23 | Xenon Pharmaceuticals Inc. | Methods and compositions employing a stearoyl-coa desaturase-hscd5 |
| FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| DE10060412A1 (de) * | 2000-12-05 | 2002-06-06 | Bayer Ag | DELTA1-Pyrroline |
| MXPA03008180A (es) * | 2001-03-15 | 2003-12-12 | Astrazeneca Ab | Inhibidores de metaloproteinasa. |
| FR2823209B1 (fr) * | 2001-04-04 | 2003-12-12 | Fournier Lab Sa | Nouvelles thiohydantoines et leur utilisation en therapeutique |
| US6911447B2 (en) * | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| KR20040010713A (ko) * | 2001-06-15 | 2004-01-31 | 야마노우치세이야쿠 가부시키가이샤 | 페닐피리딘 카보닐 피페라진 유도체 |
| JP2004536113A (ja) * | 2001-07-03 | 2004-12-02 | カイロン コーポレイション | チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物 |
| US7115607B2 (en) * | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| FR2829926B1 (fr) * | 2001-09-26 | 2004-10-01 | Oreal | Composition pour la teinture des fibres keratiniques comprenant un colorant diazoique dicationique particulier |
| US6916812B2 (en) * | 2001-10-09 | 2005-07-12 | Bristol-Myers Squibb Company | Alpha-aminoamide derivatives as melanocortin agonists |
| US6824707B2 (en) * | 2001-10-23 | 2004-11-30 | Clariant International Ltd. | Active matrix liquid crystal device and smectic liquid crystal mixture |
| EP1452525A4 (en) * | 2001-10-30 | 2005-01-26 | Nippon Shinyaku Co Ltd | AMIDE DERIVATIVES AND CORRESPONDING MEDICAMENTS |
| GB0127008D0 (en) | 2001-11-09 | 2002-01-02 | Novartis Ag | Organic compounds |
| US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| FR2833261B1 (fr) * | 2001-12-06 | 2004-07-02 | Yang Ji Chemical Company Ltd | Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii |
| US7390813B1 (en) * | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US20030166932A1 (en) * | 2002-01-04 | 2003-09-04 | Beard Richard L. | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| PL372390A1 (en) | 2002-02-05 | 2005-07-25 | Novo Nordisk A/S | Novel aryl- and heteroarylpiperazines |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| JP2005289816A (ja) * | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| JP2006505570A (ja) | 2002-10-17 | 2006-02-16 | アムジエン・インコーポレーテツド | ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用 |
| US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| DE10259382A1 (de) * | 2002-12-18 | 2004-07-01 | Abbott Gmbh & Co. Kg | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung |
| US20050130989A1 (en) * | 2003-01-28 | 2005-06-16 | Aventis Pharma S. A. | N-arylheteroaromatic products compositions containing them and use thereof |
| US6861422B2 (en) * | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| PE20050226A1 (es) * | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
| US7595316B2 (en) * | 2003-06-27 | 2009-09-29 | Banyu Pharmaceutical Co., Ltd. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| FR2857966A1 (fr) * | 2003-07-24 | 2005-01-28 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| WO2005011654A2 (en) * | 2003-07-29 | 2005-02-10 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| KR20060037409A (ko) * | 2003-07-30 | 2006-05-03 | 제논 파마슈티칼스 인크. | 피페라진 유도체 및 그의 치료제로서의 용도 |
| US7754711B2 (en) * | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| EP2316827B1 (en) * | 2003-07-30 | 2016-01-27 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their use as therapeutic agents |
| NZ544820A (en) * | 2003-08-11 | 2009-02-28 | Hoffmann La Roche | Piperazine with or-substituted phenyl group and their use as GlyT1 inhibitors |
| US20070082908A1 (en) * | 2003-08-29 | 2007-04-12 | Dainippon Sumitomo Pharma Co., Ltd. | Bicycle pyrazole derivative |
| CN100522171C (zh) * | 2003-09-09 | 2009-08-05 | 弗·哈夫曼-拉罗切有限公司 | 作为甘氨酸摄取抑制剂、用于治疗精神病的1-苯甲酰基哌嗪衍生物 |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| US20050124660A1 (en) * | 2003-10-27 | 2005-06-09 | Jochen Antel | Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| US7345043B2 (en) * | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| AR048523A1 (es) * | 2004-04-07 | 2006-05-03 | Kalypsys Inc | Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos |
| FR2868780B1 (fr) * | 2004-04-13 | 2008-10-17 | Sanofi Synthelabo | Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique |
| US7767677B2 (en) * | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| EP1804799B1 (en) * | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| US7951805B2 (en) * | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| EP1799667B1 (en) * | 2004-09-20 | 2013-03-20 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
| EP2289510A1 (en) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| JP4958787B2 (ja) | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリジン誘導体 |
| EP2316458A1 (en) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| CA2580856A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| ATE472327T1 (de) * | 2005-01-07 | 2010-07-15 | Hoffmann La Roche | Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen |
| EP2029138A1 (en) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| US7662819B2 (en) * | 2007-04-09 | 2010-02-16 | Gilead Palo Alto, Inc. | Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors |
| UA100192C2 (en) * | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
-
2005
- 2005-09-20 CN CNA2005800396667A patent/CN101083986A/zh active Pending
- 2005-09-20 EP EP05808906A patent/EP1804792A1/en not_active Withdrawn
- 2005-09-20 TW TW094132549A patent/TW200626148A/zh unknown
- 2005-09-20 BR BRPI0515477-4A patent/BRPI0515477A/pt not_active IP Right Cessation
- 2005-09-20 JP JP2007532629A patent/JP5080256B2/ja not_active Expired - Fee Related
- 2005-09-20 CA CA002580781A patent/CA2580781A1/en not_active Abandoned
- 2005-09-20 US US11/575,643 patent/US7547698B2/en not_active Expired - Fee Related
- 2005-09-20 MX MX2007003329A patent/MX2007003329A/es unknown
- 2005-09-20 AU AU2005286790A patent/AU2005286790A1/en not_active Abandoned
- 2005-09-20 AR ARP050103902A patent/AR051294A1/es unknown
- 2005-09-20 WO PCT/US2005/033738 patent/WO2006034312A1/en not_active Ceased
-
2009
- 2009-05-06 US US12/436,665 patent/US20110009414A9/en not_active Abandoned
-
2012
- 2012-06-13 JP JP2012133967A patent/JP2012193188A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513506A5 (enExample) | ||
| JP2008513516A5 (enExample) | ||
| JP2008513504A5 (enExample) | ||
| JP2008513496A5 (enExample) | ||
| JP2008513499A5 (enExample) | ||
| JP6517928B2 (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| RU2006105717A (ru) | Производные пиперазина и их применение в качестве терапевтических агентов | |
| JP2008513515A5 (enExample) | ||
| CN102292340B (zh) | 用作pde9 抑制剂的氨基-杂环类化合物 | |
| JP6505023B2 (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| CN102325753B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| JP2011523945A5 (enExample) | ||
| WO2018043747A1 (ja) | 抗ｂ型肝炎ウイルス剤 | |
| JP2007500720A5 (enExample) | ||
| CN1152870A (zh) | 杂环化合物作为多巴胺d3配位体的用途 | |
| US20160280684A1 (en) | Trk-inhibiting compound | |
| CA2597069A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| JP2008513514A5 (enExample) | ||
| RU2006105716A (ru) | Производные пиридазина и их применение в качестве терапевтических средств | |
| JP5654467B2 (ja) | ４−アミノ−３−（イミダゾリル）−ピラゾロ［３，４−ｄ］ピリミジン | |
| EA032028B1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
| KR20170055531A (ko) | 에스지씨 자극제 | |
| EA031201B1 (ru) | Соединения имидазопиридазина | |
| WO2006125180B1 (en) | Piperazine derivatives and their uses as therapeutic agents | |
| JP2024539655A5 (enExample) |